Search details
1.
Tumor-Agnostic Approvals: Insights and Practical Considerations.
Clin Cancer Res
; 30(3): 480-488, 2024 02 01.
Article
in English
| MEDLINE | ID: mdl-37792436
2.
Association of Minimal Residual Disease Negativity Rates With Progression Free Survival in Frontline Therapy Trials for Newly Diagnosed Multiple Myeloma: A Meta-analysis.
Clin Lymphoma Myeloma Leuk
; 23(5): e213-e221, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36907767
3.
Efficiency of a randomized confirmatory basket trial design constrained to control the family wise error rate by indication.
Stat Methods Med Res
; 31(7): 1207-1223, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35404188
4.
Meta-analysis of blinded and unblinded studies for ongoing aggregate safety monitoring and evaluation.
Contemp Clin Trials
; 95: 106068, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32603785
5.
Bayesian hierarchical model for safety signal detection in multiple clinical trials.
Contemp Clin Trials
; 99: 106183, 2020 12.
Article
in English
| MEDLINE | ID: mdl-33091588
6.
Lessons Learned From Multi-regional Trials With Signals of Treatment Effect Heterogeneity.
Ther Innov Regul Sci
; 54(1): 21-31, 2020 01.
Article
in English
| MEDLINE | ID: mdl-32008228
7.
Bridging blinded and unblinded analysis for ongoing safety monitoring and evaluation.
Contemp Clin Trials
; 83: 81-87, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31260790
8.
Periodic benefit-risk assessment using Bayesian stochastic multi-criteria acceptability analysis.
Contemp Clin Trials
; 67: 100-108, 2018 04.
Article
in English
| MEDLINE | ID: mdl-29505866
Results
1 -
8
de 8
1
Next >
>>